Replies to post #317151 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

The FDA could pivot from amyloid clearing to amyloid prevention on a dime if outpouring of heat.

These two things are not mutually exclusive.

Amyloid clearing is an after the fact process. 2-73 seems to have preventative capabilities.

The market place needs both. The problem is it needs a much better amyloid clearing drug than Adu**.